| CFU | Colony-forming unit |
| DFLNH | Difucosyllacto-N-hexaose |
| DFpLNH | Difucosyl-para-lacto-N-hexaose |
| DMSO-d6 | Deuterated form of dimethyl sulfoxide |
| ESI | Electrospray ionization |
| 2′FL | 2′-Fucosyllactose |
| 3′FL | 3-Fucosyllactose |
| Gal | Galactose |
| Glc | Glucose |
| GlcNAc | N-acetyl-glucosamine |
| HMOs | Human milk oligosaccharides |
| IFLNH | Isomerfucosyllacto-N-hexaose |
| IPD | Invasive pneumococcal disease |
| LDFT | Lacto-di-fructotetraose |
| LC | Liquid chromatography |
| LNDFH | Lacto-N-di-fucohexaose |
| LNFP | Lacto-N-fucopentaose |
| LNH | Lacto-N-hexaose |
| LNnH | Lacto-N-neohexaose |
| LNnT | Lacto-N-neotetraose |
| LNT | Lacto-N-tetraose |
| LST | Lacto-N-sialyltetraose |
| MFLNH | Monofucosyllacto-N-hexaose |
| MFpLNH | Monofucosyl-para-lacto-N-hexaose |
| µMAX | Maximum growth rate |
| NMR | Nuclear magnetic resonance |
| MS | Mass spectrometry |
| OD | Optical density |
| ODMAX | Maximum achievable OD |
| tMAX | Time to achieve ODMAX |
| NESp | Nonencapsulated S. pneumoniae |
| PCV | Pneumococcal conjugate vaccine |
| PGC | Porous graphitic carbon |
| 3′S3FL | 3′-Sialyl-3-fucosyllactose |
| 3′SL | 3′-Sialyllactose |
| 6′SL | 6′-Sialyllactose |
| ST | Serotype |
| TFLNH | Trifucosyllacto-N-hexaose |
| TH | Todd-Hewitt |
| UHPLC | Ultrahigh-performance liquid chromatography |